中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

17 records (took 0.02 seconds)

    EROSION PREVENTION FOR O-RINGS IN A HIGH PRESSURE INJECTION DEVICE
    2.
    发明申请
    EROSION PREVENTION FOR O-RINGS IN A HIGH PRESSURE INJECTION DEVICE 审中-公开
    高压注射装置中O形圈的防腐蚀

    公开(公告)号：WO2010067345A1

    公开(公告)日：2010-06-17

    申请号：PCT/IL2008/001594

    申请日：2008-12-08

    Applicant: PERF-ACTION TECHNOLOGIES LTD. ,  BAROR, Eyal ,  LEV KONYA, Gad

    Inventor： BAROR, Eyal ,  LEV KONYA, Gad

    IPC: A61M5/315

    CPC classification number: A61M5/30 ,  A61M5/204 ,  A61M5/31513 ,  A61M5/425

    Abstract: An injection head, including: a nozzle with a hollow inner shaft and an injection hole at the bottom for injecting fluid from the nozzle; a plunger that fits into the shaft and is adapted to push fluid from the shaft out of the injection hole; an O-ring mounted on the plunger to seal between the plunger and the shaft while pushing the fluid out of the injection hole; wherein the nozzle with the inner shaft includes an upper part and a lower part, the diameter of the lower part of the shaft is constant and the diameter of the upper part of the shaft is equal to or larger than the diameter of the lower part of the shaft; and larger than the diameter of the lower part of the shaft at least along some part of the extent of the upper part of the shaft.

    Abstract translation: 一种注射头，包括：具有中空内轴的喷嘴和在底部的喷射孔，用于从喷嘴喷射流体; 柱塞，其装配到所述轴中并且适于将流体从所述轴推出所述喷射孔; 安装在所述柱塞上的O形环，以将所述流体推出所述注入孔，从而在所述柱塞和所述轴之间进行密封; 其中具有内轴的喷嘴包括上部和下部，轴的下部的直径是恒定的，并且轴的上部的直径等于或大于下部的直径 轴; 并且至少沿着轴的上部的一部分程度大于轴的下部的直径。

    INTRADERMAL NEEDLE-LESS INJECTION MECHANISM
    3.
    发明申请
    INTRADERMAL NEEDLE-LESS INJECTION MECHANISM 审中-公开
    内窥镜无针注射机构

    公开(公告)号：WO2010016049A1

    公开(公告)日：2010-02-11

    申请号：PCT/IL2008/001077

    申请日：2008-08-06

    Applicant: PERF-ACTION TECHNOLOGIES LTD. ,  BAROR, Eyal ,  LEV KONYA, Gad

    Inventor： BAROR, Eyal ,  LEV KONYA, Gad

    IPC: A61M5/30

    CPC classification number: A61M5/30 ,  A61M5/204 ,  A61M5/2053 ,  A61M5/484

    Abstract: A needle-less fluid injection mechanism, including: a nozzle head for accepting a dose of fluid to be injected into the skin of a patient; a plunger that is adapted to be pushed into the nozzle to inject the dose of fluid from the nozzle; a hammer that is adapted to be thrust at and to collide with the plunger to cause the release of a first amount of fluid from the nozzle at a high pressure and then to release the rest of the fluid from the nozzle by continuing to push said plunger at a lower pressure until injecting the entire dose of fluid.

    Abstract translation: 一种无针流体注射机构，包括：用于接受要注射到患者皮肤中的剂量的喷嘴头; 柱塞，其适于被推入喷嘴以从喷嘴喷射剂量的流体; 锤子，其适于被推动并与柱塞碰撞，以使高压下从喷嘴释放第一量的流体，然后通过继续推动柱塞来释放流体的其余部分 在较低的压力下直到注射整个剂量的流体。

    SYSTEM FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF POLYMERIC AGENTS AND METHODS OF USE THEREOF
    6.
    发明申请
    SYSTEM FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF POLYMERIC AGENTS AND METHODS OF USE THEREOF 审中-公开
    用于聚合物的绝缘超导传输系统及其使用方法

    公开(公告)号：WO2007046103A2

    公开(公告)日：2007-04-26

    申请号：PCT/IL2006001206

    申请日：2006-10-19

    Applicant: PERF ACTION TECHNOLOGIES LTD ,  BUKSHPAN SHMUEL ,  ZILBERSTEIN GLEB

    Inventor： BUKSHPAN SHMUEL ,  ZILBERSTEIN GLEB

    IPC: F16K23/00

    CPC classification number: A61N1/325 ,  A61N1/044 ,  A61N1/0448 ,  A61N1/30

    Abstract: The present invention relates to a system for iontophoretic transdermal delivery of a non-peptidic polymeric cosmetic or therapeutic agent or of a polypeptide useful for delivery of high molecular weight cosmetic or therapeutic agents. Particularly, the present invention relates to a system comprising an iontophoresis device comprising a pharmaceutical composition comprising a non-peptidic polymeric cosmetic or therapeutic agent together with a peptide, polypeptide or protein and a pharmaceutically acceptable carrier having a pH below or above the isoelectric pH of the peptide, polypeptide or protein.

    Abstract translation: 本发明涉及用于非肽聚合物化妆品或治疗剂或可用于递送高分子量化妆品或治疗剂的多肽的离子电渗透皮递送系统。 特别地，本发明涉及包含离子电渗装置的系统，该离子电渗装置包含药物组合物，其包含非肽聚合物化妆品或治疗剂以及肽，多肽或蛋白质以及药学上可接受的载体，其pH低于或高于 肽，多肽或蛋白质。

Patent Agency Ranking